A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Clinical trial NCT05936359 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05936359
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-25
- Primary completion
- 2028-02-29
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.